Kiniksa Pharmaceuticals Azioni (NASDAQ: KNSA)

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Azioni, Quote.MetaTitle.unusual-options

Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares

Kiniksa Pharmaceuticals International PLC

Ascentage Pharma Group International - American Depository Shares

Ascentage Pharma Group

ADMA Biologics

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics

Cidara Therapeutics

Celcuity

CG Oncology

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals

Catalyst Pharmaceuticals, Inc. - Common Stock

Catalyst Pharmaceuticals

Dyne Therapeutics

Amicus Therapeutics

GRAIL

IDEAYA Biosciences

Disc Medicine

Jyong Biotech

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Ultragenyx Pharmaceutical Inc. - Common Stock

Ultragenyx Pharmaceutical

Arcus Biosciences

Scholar Rock Holding Corporation - Common Stock

Scholar Rock Holding

Telix Pharmaceuticals Limited - American Depositary Shares

Telix Pharmaceuticals

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Veracyte

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

Xenon Pharmaceuticals Inc. - Common Shares

Xenon Pharmaceuticals

Zai Lab Limited - American Depositary Shares

Zai Lab

Kiniksa Pharmaceuticals (KNSA) Previsione

Notizie

Utili

Quote.Nav.option-chain

Guidance

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Comments

Kiniksa Pharmaceuticals Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO